Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
Institutions: Biomedical Research Networking Center on Neurodegenerative Diseases, Hospital Universitario Ramón y Cajal, Universität Ulm, Istituto Neurologico Mediterraneo, University of Münster, Cardiff University, University of Cambridge, St. Josef-Hospital, Ruhr University Bochum, University of Graz, NeuroSearch (Denmark)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2167353335
